PIPERAZINE DERIVATIVES AS PARP1 INHIBITIORS - NINGBO NEWBAY TECH DEVELOPMENT CO LTD

Title:

PIPERAZINE DERIVATIVES AS PARP1 INHIBITIORS

Document Type and Number:

WIPO Patent Application WO/2023/207284

Kind Code:

A1

Abstract:

Disclosed are piperazine derivatives and pharmaceutically acceptable salts thereof that inhibit the Poly (ADP-ribose) polymerase (PARP) family of enzymes. Also disclosed is the use of these compounds or pharmaceutically acceptable salts thereof in the treatment of diseases.

More Like This:

JP6465813	5-Hydroxy-4- (trifluoromethyl) pyrazolopyridine derivative
JP2011521959	New replaced indole
JP2024508948	Compounds with tetrahydroindolizine-1-carboxamide as BCL-2 inhibitors

Inventors:

WANG TINGZHONG (CN)
SHEN ZHENHAI (CN)
TALBOT ERIC P A (GB)
BATEMAN JOSEPH M (GB)
RAHEMTULLA BENJAMIN F (GB)
MOROGLU MUSTAFA (GB)
LADDUWAHETTY TAMMY (GB)

Application Number:

PCT/CN2023/077273

Publication Date:

November 02, 2023

Filing Date:

February 20, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

NINGBO NEWBAY TECH DEVELOPMENT CO LTD (CN)

International Classes:

C07D471/04; A61K31/4353; A61K31/4375; A61K31/495; A61P35/00; C07D401/14; C07D403/14

Domestic Patent References:

WO2022222995A1	2022-10-27
WO2022228387A1	2022-11-03
WO2022223025A1	2022-10-27
WO2009053373A1	2009-04-30
WO2021260092A1	2021-12-30

Foreign References:

CN102341394A	2012-02-01
CN114144413A	2022-03-04

Attorney, Agent or Firm:

KING & WOOD MALLESONS (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: COMPOUNDS AS PARP1 INHIBITIORS

Next Patent: DISPLAY MODULE AND DISPLAY APPARATUS